首页> 外文期刊>Genetic testing and molecular biomarkers >Aldosterone Synthase Gene (CYP11B2) -344C/T Polymorphism Contributes to the Risk of Recurrent Cerebral Ischemia
【24h】

Aldosterone Synthase Gene (CYP11B2) -344C/T Polymorphism Contributes to the Risk of Recurrent Cerebral Ischemia

机译:醛固酮合酶基因(CYP11B2)-344C / T多态性有助于复发性脑缺血的风险

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Accumulating evidence suggests that CYP11B2 rs1799998 (-344C/T) polymorphism is independently associated with an increased risk of stroke. Our aim was to determine whether -344C/T also predisposes to recurrent cerebral ischemia following in patients with symptomatic intracranial atherosclerosis disease (ICAD). Methods: Genotypes of the CYP11B2 -344C/T polymorphism were determined by polymerase chain reaction-restriction fragment length polymorphism. A total of 208 ICAD patients were enrolled and underwent a long-term clinical follow-up to detect the recurrent cerebral ischemia. Results: During a median follow-up time of 35 months, 40 recurrent strokes (19.2%) were documented. Kaplan-Meier and multivariable Cox regression analyses adjusted for age, gender, and other cardiovascular risk factors identified that the presence of the TT genotype within the CYP11B2 -344C/T polymorphism was associated with an increased risk of 1.98-fold for recurrent cerebral ischemia (the hazard ratio 1.98, 95% confidence interval 1.16-3.41; p = 0.01). Conclusions: Our findings suggest that the -344C/T polymorphism of the CYP11B2 gene confers an increased risk of recurrent cerebral ischemia.
机译:背景:越来越多的证据表明,CYP11B2 rs1799998(-344C / T)多态性与中风风险的增加独立相关。我们的目的是确定在患有症状性颅内动脉粥样硬化疾病(ICAD)的患者中,-344C / T是否也易诱发复发性脑缺血。方法:采用聚合酶链反应-限制性酶切片段长度多态性检测CYP11B2基因-344C / T的基因型。共有208名ICAD患者入组并进行了长期临床随访,以发现复发性脑缺血。结果:在中位随访期35个月内,记录了40例复发性中风(19.2%)。根据年龄,性别和其他心血管风险因素进行调整的Kaplan-Meier和多变量Cox回归分析确定,CYP11B2 -344C / T多态性内TT基因型的存在与复发性脑缺血风险增加1.98倍相关(危险比1.98,95%置信区间1.16-3.41; p = 0.01)。结论:我们的发现表明CYP11B2基因的-344C / T多态性增加了复发性脑缺血的风险。

著录项

  • 来源
    《Genetic testing and molecular biomarkers》 |2013年第7期|548-552|共5页
  • 作者单位

    Department of Neurology-Muscle Brain Hospital of People's Hospital of Zhengzhou 33 Huanghe Road Zhengzhou 45000 China;

    Department of Neurology-Muscle, Brain Hospital of People's Hospital of Zhengzhou, Zhengzhou, Henan Province, China;

    Department of Neurology-Muscle, Brain Hospital of People's Hospital of Zhengzhou, Zhengzhou, Henan Province, China;

    Department of Neurology-Muscle, Brain Hospital of People's Hospital of Zhengzhou, Zhengzhou, Henan Province, China;

    Department of Neurology-Muscle, Brain Hospital of People's Hospital of Zhengzhou, Zhengzhou, Henan Province, China;

    Department of Neurology-Muscle, Brain Hospital of People's Hospital of Zhengzhou, Zhengzhou, Henan Province, China;

    Department of Neurology-Muscle, Brain Hospital of People's Hospital of Zhengzhou, Zhengzhou, Henan Province, China;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:17:35

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号